Today, Venture Global announced that it has notified its long-term customers that its Calcasieu Pass facility will commence commercial operations on April 15, 2025. The facility will achieve its commercial operation date, or COD, in under 68 months from its August 2019 final investment decision, despite substantial impacts including two hurricanes, the COVID-19 pandemic, and major unforeseen manufacturing issues, such as with the Heat Recovery Steam Generators (HRSGs) forming part of the facili...

With 2.2 billion people lacking safe water, communities, businesses, and NGOs are taking bold action this World Water Day to accelerate solutions. From March 17-22, thousands of volunteers worldwide will mobilize to improve water security—through cleanups, education programs, and projects expanding access to safe water, sanitation, and hygiene (WASH). “Around the world, volunteers are driving meaningful progress toward providing clean water and sanitation for communities everywhere,” said Aust...

OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, is introducing significant enhancements to its Infinity® Automated Storage and Retrieval System (AS/RS). Enhanced features include a 15 percent increase in the system’s storage payload, along with new storage slotting capabilities. The Infinity AS/RS, launched in 2022, combines unparalleled storage density, configurability and flexibility to meet the most...

Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of both atopic dermatitis and prurigo nodularis in the UK and Switzerland, respectively. Specifically, the approvals are for nemolizumab’s subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors in adults and ad...